杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/04/14 | 1,404 | 1,419 | 1,391 | 1,410 | +2 | +0.1% | 147,000 |
2011/04/13 | 1,398 | 1,414 | 1,398 | 1,408 | +8 | +0.6% | 54,000 |
2011/04/12 | 1,403 | 1,414 | 1,395 | 1,400 | -16 | -1.1% | 119,000 |
2011/04/11 | 1,415 | 1,424 | 1,397 | 1,416 | +18 | +1.3% | 231,000 |
2011/04/08 | 1,372 | 1,409 | 1,371 | 1,398 | +27 | +2% | 167,000 |
2011/04/07 | 1,370 | 1,388 | 1,364 | 1,371 | +3 | +0.2% | 233,000 |
2011/04/06 | 1,401 | 1,404 | 1,362 | 1,368 | -22 | -1.6% | 296,000 |
2011/04/05 | 1,406 | 1,408 | 1,379 | 1,390 | -9 | -0.6% | 154,000 |
2011/04/04 | 1,402 | 1,412 | 1,393 | 1,399 | -10 | -0.7% | 163,000 |
2011/04/01 | 1,422 | 1,430 | 1,401 | 1,409 | -7 | -0.5% | 181,000 |
2011/03/31 | 1,418 | 1,418 | 1,402 | 1,416 | +2 | +0.1% | 165,000 |
2011/03/30 | 1,388 | 1,414 | 1,381 | 1,414 | +16 | +1.1% | 207,000 |
2011/03/29 | 1,413 | 1,413 | 1,387 | 1,398 | -15 | -1.1% | 192,000 |
2011/03/28 | 1,436 | 1,436 | 1,400 | 1,413 | -12 | -0.8% | 131,000 |
2011/03/25 | 1,445 | 1,445 | 1,400 | 1,425 | +6 | +0.4% | 147,000 |
2011/03/24 | 1,381 | 1,421 | 1,372 | 1,419 | +25 | +1.8% | 255,000 |
2011/03/23 | 1,408 | 1,424 | 1,382 | 1,394 | -13 | -0.9% | 164,000 |
2011/03/22 | 1,396 | 1,407 | 1,390 | 1,407 | +41 | +3% | 160,000 |
2011/03/18 | 1,359 | 1,383 | 1,340 | 1,366 | +11 | +0.8% | 251,000 |
2011/03/17 | 1,260 | 1,369 | 1,250 | 1,355 | +35 | +2.7% | 314,000 |
2011/03/16 | 1,261 | 1,346 | 1,256 | 1,320 | +29 | +2.2% | 455,000 |
2011/03/15 | 1,372 | 1,372 | 1,220 | 1,291 | -111 | -7.9% | 339,000 |
2011/03/14 | 1,380 | 1,484 | 1,353 | 1,402 | -90 | -6% | 269,000 |
2011/03/11 | 1,493 | 1,510 | 1,486 | 1,492 | -17 | -1.1% | 271,000 |
2011/03/10 | 1,515 | 1,523 | 1,508 | 1,509 | -15 | -1% | 173,000 |
2011/03/09 | 1,516 | 1,539 | 1,507 | 1,524 | +9 | +0.6% | 271,000 |
2011/03/08 | 1,514 | 1,527 | 1,514 | 1,515 | +5 | +0.3% | 163,000 |
2011/03/07 | 1,530 | 1,530 | 1,500 | 1,510 | -18 | -1.2% | 267,000 |
2011/03/04 | 1,501 | 1,536 | 1,495 | 1,528 | +8 | +0.5% | 502,000 |
2011/03/03 | 1,494 | 1,531 | 1,480 | 1,520 | +79 | +5.5% | 746,000 |
2011/03/02 | 1,467 | 1,472 | 1,439 | 1,441 | -33 | -2.2% | 578,000 |
2011/03/01 | 1,492 | 1,521 | 1,444 | 1,474 | -15 | -1% | 756,000 |
2011/02/28 | 1,492 | 1,492 | 1,474 | 1,489 | +9 | +0.6% | 201,000 |
2011/02/25 | 1,509 | 1,509 | 1,468 | 1,480 | -13 | -0.9% | 317,000 |
2011/02/24 | 1,502 | 1,510 | 1,485 | 1,493 | -11 | -0.7% | 197,000 |
2011/02/23 | 1,514 | 1,531 | 1,503 | 1,504 | -4 | -0.3% | 179,000 |
2011/02/22 | 1,523 | 1,527 | 1,505 | 1,508 | -17 | -1.1% | 171,000 |
2011/02/21 | 1,522 | 1,535 | 1,522 | 1,525 | -13 | -0.8% | 214,000 |
2011/02/18 | 1,525 | 1,547 | 1,508 | 1,538 | +17 | +1.1% | 283,000 |
2011/02/17 | 1,540 | 1,540 | 1,519 | 1,521 | -21 | -1.4% | 509,000 |
2011/02/16 | 1,564 | 1,564 | 1,536 | 1,542 | -22 | -1.4% | 225,000 |
2011/02/15 | 1,539 | 1,573 | 1,533 | 1,564 | +15 | +1% | 159,000 |
2011/02/14 | 1,559 | 1,569 | 1,543 | 1,549 | -15 | -1% | 282,000 |
2011/02/10 | 1,566 | 1,575 | 1,555 | 1,564 | -3 | -0.2% | 282,000 |
2011/02/09 | 1,544 | 1,578 | 1,544 | 1,567 | +33 | +2.2% | 287,000 |
2011/02/08 | 1,536 | 1,549 | 1,533 | 1,534 | -3 | -0.2% | 161,000 |
2011/02/07 | 1,523 | 1,550 | 1,518 | 1,537 | +17 | +1.1% | 342,000 |
2011/02/04 | 1,513 | 1,542 | 1,510 | 1,520 | +6 | +0.4% | 251,000 |
2011/02/03 | 1,503 | 1,524 | 1,495 | 1,514 | +11 | +0.7% | 156,000 |
2011/02/02 | 1,499 | 1,518 | 1,488 | 1,503 | +17 | +1.1% | 262,000 |
3451~
3500
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 81,800円 | +20.3% | - | 0.00% | 145.04倍 | 1.08倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム